356 related articles for article (PubMed ID: 34246602)
21. Physical Rehabilitation in Older Patients Hospitalized with Acute Heart Failure and Diabetes: Insights from REHAB-HF.
Murray EM; Whellan DJ; Chen H; Bertoni AG; Duncan P; Pastva AM; Kitzman DW; Mentz RJ
Am J Med; 2022 Jan; 135(1):82-90. PubMed ID: 34516959
[TBL] [Abstract][Full Text] [Related]
22. Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort.
Quiroz R; Doros G; Shaw P; Liang CS; Gauthier DF; Sam F
Am J Cardiol; 2014 Feb; 113(4):691-6. PubMed ID: 24484862
[TBL] [Abstract][Full Text] [Related]
23. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
[TBL] [Abstract][Full Text] [Related]
24. Early Longitudinal Change in Heart Failure Health Status Following Initiation of Canagliflozin.
Mohebi R; Jones PG; Spertus JA; Lingvay I; Lanfear DE; Gosch KL; Birmingham M; Kosiborod MN; Butler J; Januzzi JL
JACC Heart Fail; 2024 Apr; 12(4):711-718. PubMed ID: 38385941
[TBL] [Abstract][Full Text] [Related]
25. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
[TBL] [Abstract][Full Text] [Related]
26. Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial.
Kosiborod MN; Verma S; Borlaug BA; Butler J; Davies MJ; Jon Jensen T; Rasmussen S; Erlang Marstrand P; Petrie MC; Shah SJ; Ito H; Schou M; Melenovský V; Abhayaratna W; Kitzman DW;
Circulation; 2024 Jan; 149(3):204-216. PubMed ID: 37952180
[TBL] [Abstract][Full Text] [Related]
27. Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Davis BR; Kostis JB; Simpson LM; Black HR; Cushman WC; Einhorn PT; Farber MA; Ford CE; Levy D; Massie BM; Nawaz S;
Circulation; 2008 Nov; 118(22):2259-67. PubMed ID: 19001024
[TBL] [Abstract][Full Text] [Related]
28. Current conditions and significance of outpatient cardiac rehabilitation and home nursing-care services in heart failure patients with mid-range or preserved ejection fraction: post-hoc analysis of the REAL-HF registry.
Kitagawa T; Hidaka T; Watanabe N; Naka M; Yamaguchi M; Kanai K; Isobe M; Kihara Y; Nakano Y;
Heart Vessels; 2022 May; 37(5):745-754. PubMed ID: 34731295
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Significance of New-Onset Atrial Fibrillation in Heart Failure with Preserved, Mid-Range, and Reduced Ejection Fraction Following Acute Myocardial Infarction: Data from the NOAFCAMI-SH Registry.
Hao C; Luo J; Liu B; Xu W; Li Z; Gong M; Qin X; Shi B; Wei Y
Clin Interv Aging; 2022; 17():479-493. PubMed ID: 35444413
[TBL] [Abstract][Full Text] [Related]
30. Patient-Reported Frailty and Functional Status in Heart Failure With Preserved Ejection Fraction: Insights From VITALITY-HFpEF.
Kaul P; Rathwell S; Lam CSP; Westerhout CM; Spertus JA; Anstrom KJ; Blaustein RO; Ezekowitz JA; Pieske B; Roessig L; Butler J; Armstrong PW;
JACC Heart Fail; 2023 Apr; 11(4):392-403. PubMed ID: 36881394
[TBL] [Abstract][Full Text] [Related]
31. Tailored risk assessment of 90-day acute heart failure readmission or all-cause death to heart failure with preserved versus reduced ejection fraction.
Park J; Zhong X; Babaie Sarijaloo F; Wokhlu A
Clin Cardiol; 2022 Apr; 45(4):370-378. PubMed ID: 35077583
[TBL] [Abstract][Full Text] [Related]
32. Empagliflozin in Heart Failure With Predicted Preserved Versus Reduced Ejection Fraction: Data From the EMPA-REG OUTCOME Trial.
Savarese G; Uijl A; Lund LH; Anker SD; Asselbergs F; Fitchett D; Inzucchi SE; Koudstaal S; Ofstad AP; Schrage B; Vedin O; Wanner C; Zannad F; Zwiener I; Butler J
J Card Fail; 2021 Aug; 27(8):888-895. PubMed ID: 34364665
[TBL] [Abstract][Full Text] [Related]
33. Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction.
Kosiborod MN; Bhatt AS; Claggett BL; Vaduganathan M; Kulac IJ; Lam CSP; Hernandez AF; Martinez FA; Inzucchi SE; Shah SJ; de Boer RA; Jhund PS; Desai AS; Fang JC; Han Y; Comin-Colet J; Vardeny O; Lindholm D; Wilderäng U; Bengtsson O; McMurray JJV; Solomon SD
J Am Coll Cardiol; 2023 Feb; 81(5):460-473. PubMed ID: 36526515
[TBL] [Abstract][Full Text] [Related]
34. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
[No Abstract] [Full Text] [Related]
35. Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction.
Kalogeropoulos AP; Fonarow GC; Georgiopoulou V; Burkman G; Siwamogsatham S; Patel A; Li S; Papadimitriou L; Butler J
JAMA Cardiol; 2016 Aug; 1(5):510-8. PubMed ID: 27434402
[TBL] [Abstract][Full Text] [Related]
36. Phenotyping congestion in patients with acutely decompensated heart failure with preserved and reduced ejection fraction: The Decongestion duRing therapY for acute decOmpensated heart failure in HFpEF vs HFrEF- DRY-OFF study.
Cogliati C; Ceriani E; Gambassi G; De Matteis G; Perlini S; Perrone T; Muiesan ML; Salvetti M; Leidi F; Ferrara F; Sabbà C; Suppressa P; Fracanzani A; Montano N; Fiorelli E; Tripepi G; Gori M; Pitino A; Pietrangelo A
Eur J Intern Med; 2022 Mar; 97():69-77. PubMed ID: 34844795
[TBL] [Abstract][Full Text] [Related]
37. How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) Trial.
Maisel AS; Shah KS; Barnard D; Jaski B; Frivold G; Marais J; Azer M; Miyamoto MI; Lombardo D; Kelsay D; Iqbal N; Taub PR; Kupfer K; Lee E; Clopton P; Zile M; Greenberg B
J Card Fail; 2016 Apr; 22(4):283-93. PubMed ID: 26433086
[TBL] [Abstract][Full Text] [Related]
38. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
Sartipy U; Dahlström U; Fu M; Lund LH
JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of cardiac I-123-metaiodobenzylguanidine imaging in patients with reduced, mid-range, and preserved left ventricular ejection fraction admitted for acute decompensated heart failure: a prospective study in Osaka Prefectural Acute Heart Failure Registry (OPAR).
Seo M; Yamada T; Tamaki S; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Abe M; Nakamura J; Yamamoto K; Kayama K; Kawahira M; Tanabe K; Kimura T; Ueda K; Sakamoto D; Sakata Y; Fukunami M
Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(1):58-66. PubMed ID: 32091079
[TBL] [Abstract][Full Text] [Related]
40. Relationship of Race With Functional and Clinical Outcomes With the REHAB-HF Multidomain Physical Rehabilitation Intervention for Older Patients With Acute Heart Failure.
Gilbert ON; Mentz RJ; Bertoni AG; Kitzman DW; Whellan DJ; Reeves GR; Duncan PW; Nelson MB; Blumer V; Chen H; Reed SD; Upadhya B; O'Connor CM; Pastva AM
J Am Heart Assoc; 2023 Nov; 12(21):e030588. PubMed ID: 37889196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
